Phibro Animal Health (NASDAQ:PAHC) Shares Down 6.5% – Here’s What Happened

Phibro Animal Health Co. (NASDAQ:PAHC) traded down 6.5% during mid-day trading on Wednesday . The stock traded as low as $24.11 and last traded at $24.15. 162,313 shares changed hands during mid-day trading, a decline of 22% from the average session volume of 207,590 shares. The stock had previously closed at $25.82.

Analyst Ratings Changes

PAHC has been the subject of a number of recent research reports. Barclays upped their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Morgan Stanley increased their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Trading Down 6.4 %

The firm has a market capitalization of $978.89 million, a P/E ratio of 50.35, a PEG ratio of 0.50 and a beta of 0.52. The business’s 50 day moving average is $22.17 and its two-hundred day moving average is $21.99. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is currently 100.00%.

Institutional Trading of Phibro Animal Health

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Sterling Capital Management LLC boosted its stake in Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock valued at $394,000 after buying an additional 448 shares in the last quarter. Rhumbline Advisers lifted its holdings in Phibro Animal Health by 0.6% in the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after acquiring an additional 484 shares during the last quarter. Los Angeles Capital Management LLC boosted its position in shares of Phibro Animal Health by 2.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after purchasing an additional 503 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares during the last quarter. Finally, New York State Teachers Retirement System raised its holdings in shares of Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after purchasing an additional 775 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.